Global Perspectives in Current and Future Management of CRC
CRC-specific discussions on therapeutic advances and their application in clinical decision-making
January 20, 2024
FACULTY CHAIR
Tanios S. Bekaii-Saab, MD, FACP
Mayo Clinic, Phoenix, AZ, USA
Faculty Members
Zev Wainberg, MD
University of California, Los Angeles, CA, USA
Mariano Dioca, MD
Instituto de Oncologia Ángel H. Roffo, Buenos Aires, Argentina
Kristen Ciombor, MD
Vanderbilt University, Nashville, TN, USA
Michael Overman, MD
MD Anderson Cancer Center, Houston, TX, USA
Aparna Parikh, MD
Tucker Gosnell Center for Gastrointestinal Cancers, Boston, MA, USA
Julien Taieb, MD, PhD
Georges Pompidou European Hospital, Paris, France
Thierry André, MD
Sorbonne Université, Paris, France
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Metastatic CRC – Targeted Therapies
- Metastatic CRC – Immunotherapy
- Predictive and Prognostic Biomarkers in CRC
- Rectal Cancer
